Commodore Capital’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Commodore Capital’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,500,000	Closed	-$17.1M	–	43
2023 Q4	$17.1M	Buy	+1,500,000	New	+$11.8M	1.49%	24

Commodore Capital's HARP Position: Q1 2024 in Review

Commodore Capital sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 1,500,000 shares — an estimated $17.1M sold.

Commodore Capital first reported a position in HARP in Q4 2023 and held it in 1 quarter. The position peaked at $17.1M in Q4 2023. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

Commodore Capital reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Commodore Capital sold 1,500,000 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $17.1M.
Commodore Capital first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Commodore Capital's Harpoon Therapeutics, Inc. Common Stock position peaked at $17.1M in Q4 2023.
0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Commodore Capital's 13F filing for Q1 2024, filed 15 May 2024.